SCHEMBL1998512

SCHEMBL1998512

COC(C)(C)CN1CCC(n2nc(C3=C(c4c[nH]c5ccsc45)C(=O)NC3=O)c3ccccc32)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 11/20 0.39
PRKCE Q02156 10/20 0.39
PRKCB P05771 10/20 0.39
CAMK2D Q13557 9/20 0.39
PRKCH P24723 9/20 0.39
PRKCD Q05655 9/20 0.39
PRKCG P05129 9/20 0.39
CAMK2B Q13554 6/20 0.39
CAMK2G Q13555 6/20 0.39
CAMK2A Q9UQM7 6/20 0.39
PRKCZ Q05513 5/20 0.39
SRC P12931 3/20 0.39
PRKCQ Q04759 4/20 0.35
GSK3B P49841 4/20 0.35
PIM1 P11309 4/20 0.35
PDGFRB P09619 2/20 0.35
RPS6KB1 P23443 2/20 0.35
CDK2 P24941 2/20 0.35
AXL P30530 2/20 0.35
FLT4 P35916 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994738 0.91 PRKCA (0.40) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1995704 0.89 CAMK2D (0.41) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL2001228 0.89 PRKCB (0.37) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1992944 0.88 PRKACA (0.44) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1990865 0.86 CAMK2D (0.45) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1991219 0.85 CAMK2D (0.56) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1994230 0.85 PRKCB (0.43) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1997240 0.85 CAMK2D (0.41) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1989694 0.82 PRKCH (0.43) PRKCAPRKCEPRKCBCAMK2DPRKCH
SCHEMBL1989963 0.79 PRKCB (0.38) PRKCAPRKCEPRKCBCAMK2DPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCA 3438/4885PRKCE 3431/4885PRKCB 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.